Franklin India Technology Fund-Growth vs Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option

Side-by-side comparison of NAV, returns, expense ratio and star rating.

TopFund Analysis

Franklin India Technology Fund-Growth appears stronger in terms of star rating with a 5-star rating compared to Nippon India Pharma Fund's 2-star rating, indicating a potentially better quality of management and performance. However, investors should note that while the Franklin fund has a higher star rating, it has lower returns over 1Y, 3Y, and 5Y periods compared to the Nippon fund, which offers higher returns but at a slightly lower expense ratio of 0.99%. For investors deciding between these two funds, the choice may hinge on whether they prioritize higher returns or a more highly rated fund.

Franklin Templeton Mutual Fund

Franklin India Technology Fund-Growth

Franklin Templeton Mutual Fund

★★★★★

Equity · Sectoral

Nippon India Mutual Fund

Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option

Nippon India Mutual Fund

★★★★★

Equity · Sectoral

Metric Franklin India Technol... Nippon India Pharma Fu...
NAV ₹544.36 ₹646.81
Star Rating ★★★★★ ★★
Expense Ratio 1.16% 0.99%
AUM ₹1,742 Cr ₹9,166 Cr
1M Return +5.45% +3.04%
3M Return -0.29% +0.74%
6M Return +13.03% +7.9%
1Y Return -5.8% +10.92%
3Y CAGR +10.29% +18.96%
5Y CAGR +7.22% +14.59%
Risk Level — —
Fund Manager Anand Radhakrishnan, Srikesh Nair, Varun Sharma Sailesh Raj Bhan